{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:55:08Z","timestamp":1777139708815,"version":"3.51.4"},"reference-count":103,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2241,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T00:00:00Z","timestamp":1577491200000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>While anti-cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio-oncology units in Europe and a growing interest of clinicians and researchers. The Heart Failure 2019 meeting of the Heart Failure Association of the European Society of Cardiology in Athens has therefore created a scientific programme that included four dedicated sessions on the topic along with several additional lectures. The major points that were discussed at the congress included the implementation and delivery of a cardio-oncology service, the collaboration among cardio-oncology experts, and the risk stratification, prevention, and early recognition of cardiotoxicity. Furthermore, sessions addressed the numerous different anti-cancer therapies associated with cardiotoxic effects and provided guidance on how to treat cancer patients who develop cardiovascular disease before, during, and after treatment.<\/jats:p>","DOI":"10.1002\/ehf2.12551","type":"journal-article","created":{"date-parts":[[2019,12,29]],"date-time":"2019-12-29T01:59:03Z","timestamp":1577584743000},"page":"1140-1148","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Recent Advances in Cardio-Oncology: A Report from the \u2018Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019\u2019"],"prefix":"10.1093","volume":"6","author":[{"given":"Markus S.","family":"Anker","sequence":"first","affiliation":[{"name":"Division of Cardiology and Metabolism, Department of Cardiology, Charit\u00e9 and Berlin Institute of Health Center for Regenerative Therapies (BCRT) and DZHK (German Centre for Cardiovascular Research) , partner site Berlin and Department of Cardiology, Charit\u00e9 Campus Benjamin Franklin, Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Hadzibegovic","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Metabolism, Department of Cardiology, Charit\u00e9 and Berlin Institute of Health Center for Regenerative Therapies (BCRT) and DZHK (German Centre for Cardiovascular Research) , partner site Berlin and Department of Cardiology, Charit\u00e9 Campus Benjamin Franklin, Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Lena","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Metabolism, Department of Cardiology, Charit\u00e9 and Berlin Institute of Health Center for Regenerative Therapies (BCRT) and DZHK (German Centre for Cardiovascular Research) , partner site Berlin and Department of Cardiology, Charit\u00e9 Campus Benjamin Franklin, Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yury","family":"Belenkov","sequence":"additional","affiliation":[{"name":"Sechenov Medical University , Moscow ,","place":["Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Bergler-Klein","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen , University Medical Center Groningen, Groningen ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Farmakis","sequence":"additional","affiliation":[{"name":"University of Cyprus Medical School , Nicosia ,","place":["Cyprus"]},{"name":"Department of Cardiology, Cardio-Oncology Clinic, Heart Failure Unit, Athens University Hospital \u2018Attikon\u2019, National and Kapodistrian University of Athens , Athens ,","place":["Greece"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Pneumology, Heart Center G\u00f6ttingen, German Center for Cardiovascular Medicine (DZHK), University of G\u00f6ttingen Medical Center, Georg-August-University , G\u00f6ttingen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaza","family":"Iakobishvili","sequence":"additional","affiliation":[{"name":"Department of Community Cardiology, Clalit Health Fund, and Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Maack","sequence":"additional","affiliation":[{"name":"Comprehensive Heart Failure Center (CHFC), University Clinic W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"Pudil","sequence":"additional","affiliation":[{"name":"1st Department of Medicine\u2013Cardioangiology, Faculty of Medicine, University Hospital , Hradec Kr\u00e1lov\u00e9 ,","place":["Czech Republic"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadi","family":"Skouri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, American University of Beirut Medical Center , Beirut ,","place":["Lebanon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Cohen-Solal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lariboisi\u00e8re Hospital and U942 INSERM, BIOCANVAS (Biomarqueurs Cardiovasculaires), Paris University , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo G.","family":"Tocchetti","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences and Interdepartmental Center for Clinical and Translational Sciences (CIRCET), Federico II University , Naples ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.S.","family":"Coats","sequence":"additional","affiliation":[{"name":"IRCCS San Raffaele , Rome ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petar M.","family":"Seferovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Heart Failure Center, Belgrade University Medical Center, University of Belgrade , Belgrade ,","place":["Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander R.","family":"Lyon","sequence":"additional","affiliation":[{"name":"Royal Brompton Hospital and Imperial College London , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,12,28]]},"reference":[{"key":"2026012115084535000_ehf212551-bib-0001","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOSCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"2026012115084535000_ehf212551-bib-0002","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026012115084535000_ehf212551-bib-0003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000323740","article-title":"Chronic kidney disease in cancer patients: an independent predictor of cancer-specific mortality","volume":"33","author":"Na","year":"2011","journal-title":"Am J Nephrol"},{"key":"2026012115084535000_ehf212551-bib-0004","first-page":"253","article-title":"Chronic kidney disease and cancer: a troubling connection","volume":"23","author":"Stengel","year":"2010","journal-title":"J Nephrol"},{"key":"2026012115084535000_ehf212551-bib-0005","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/ajh.24915","article-title":"Liver dysfunction in chronic lymphocytic leukemia: prevalence, outcomes, and pathological findings","volume":"92","author":"Hampel","year":"2017","journal-title":"Am J Hematol"},{"key":"2026012115084535000_ehf212551-bib-0006","doi-asserted-by":"crossref","first-page":"815105","DOI":"10.1155\/2013\/815105","article-title":"Liver injury induced by anticancer chemotherapy and radiation therapy","volume":"2013","author":"Maor","year":"2013","journal-title":"Int J Hepatol"},{"key":"2026012115084535000_ehf212551-bib-0007","first-page":"106","article-title":"Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management","volume":"25","author":"Boussios","year":"2012","journal-title":"Ann Gastroenterol"},{"key":"2026012115084535000_ehf212551-bib-0008","first-page":"313","article-title":"Bowen JM; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology (MASCC\/ISOO)","volume":"21","author":"Gibson","year":"2013","journal-title":"Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer"},{"key":"2026012115084535000_ehf212551-bib-0009","doi-asserted-by":"crossref","first-page":"628","DOI":"10.6004\/jnccn.2012.0064","article-title":"Cancer- and chemotherapy-induced anemia","volume":"10","author":"Rodgers","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"2026012115084535000_ehf212551-bib-0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ajh.23628","article-title":"Diagnosis and treatment of cancer-related anemia","volume":"89","author":"Gilreath","year":"2014","journal-title":"Am J Hematol"},{"key":"2026012115084535000_ehf212551-bib-0011","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jcsm.12199","article-title":"Muscle mass as a target to reduce fatigue in patients with advanced cancer","volume":"8","author":"Neefjes","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115084535000_ehf212551-bib-0012","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jcsm.12294","article-title":"Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue","volume":"9","author":"Bohlen","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115084535000_ehf212551-bib-0013","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40121-017-0146-1","article-title":"Infections in cancer patients with solid tumors: a review","volume":"6","author":"Rolston","year":"2017","journal-title":"Infect Dis Ther"},{"key":"2026012115084535000_ehf212551-bib-0014","article-title":"The role of systemic inflammation in cancer-associated muscle wasting and rationale for exercise as a therapeutic intervention","volume":"3","author":"Cole","year":"2018","journal-title":"JCSM Clin Rep"},{"key":"2026012115084535000_ehf212551-bib-0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jcsm.12156","article-title":"Cancer anorexia: hypothalamic activity and its association with inflammation and appetite-regulating peptides in lung cancer","volume":"8","author":"Molfino","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115084535000_ehf212551-bib-0016","article-title":"The experience of weight loss and its associated burden in patients with non-small cell lung cancer: results of an online survey","volume":"2","author":"Rodriguez","year":"2017","journal-title":"JCSM Clin Rep"},{"key":"2026012115084535000_ehf212551-bib-0017","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/ehf2.12389","article-title":"Metabolic disorders in heart failure and cancer","volume":"5","author":"Lena","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0018","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jcsm.12234","article-title":"Sarcopenia is negatively associated with long-term outcoes in locally advanced rectal cancer","volume":"9","author":"Choi","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115084535000_ehf212551-bib-0019","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jpainsymman.2015.12.336","article-title":"Prevalence of neuropathic pain in cancer patients: pooled estimates from a systematic review of published literature and results from a survey conducted in 50 Italian palliative care centers","volume":"51","author":"Roberto","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"2026012115084535000_ehf212551-bib-0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/0284186X.2016.1167958","article-title":"Pain following cancer treatment: guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain","volume":"55","author":"Nijs","year":"2016","journal-title":"Acta Oncol"},{"key":"2026012115084535000_ehf212551-bib-0021","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: Part 1","volume":"70","author":"Chang","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0022","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/ehf2.12386","article-title":"and for the Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology. Modern-day cardio-oncology: a report from the \u2018Heart Failure and World Congress on Acute Heart Failure 2018\u2019","volume":"5","author":"Anker","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0023","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012115084535000_ehf212551-bib-0024","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.1049","article-title":"Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience","volume":"20","author":"Fornaro","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0025","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ejhf.822","article-title":"Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland","volume":"19","author":"Mamas","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0026","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ehf2.12314","article-title":"The need for dedicated advanced heart failure units to optimize heart failure care: impact of optimized advanced heart failure unit care on heart transplant outcome in high-risk patients","volume":"5","author":"Kreusser","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0027","first-page":"2463","article-title":"Functional status and quality of life among breast cancer survivors with heart failure: results of the Medicare Health Outcomes Survey","volume":"25","author":"Harrison","year":"2017","journal-title":"Support Care Cancer"},{"key":"2026012115084535000_ehf212551-bib-0028","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ehf2.12209","article-title":"Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)","volume":"4","author":"Saitoh","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0029","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ehf2.12125","article-title":"Palliative care in heart failure: facts and numbers","volume":"4","author":"Riley","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0030","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2017.03.528","article-title":"Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research","volume":"69","author":"Costanzo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0031","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/ejhf.1098","article-title":"Co-morbidities in heart failure beginning to sprout-and no end in sight?","volume":"19","author":"von Haehling","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0032","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ejhf.901","article-title":"Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality","volume":"20","author":"Platz","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0033","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ehf2.12156","article-title":"Gender-adjusted and age-adjusted economic burden of congestive heart failure: cost and disability-adjusted life-year analysis","volume":"4","author":"Salem","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCA.0000000000000444","article-title":"Treatment of coronary artery disease in cancer survivors: an emerging challenge","volume":"28","author":"Hess","year":"2017","journal-title":"Coron Artery Dis"},{"key":"2026012115084535000_ehf212551-bib-0035","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","article-title":"Insights into onco-cardiology: atrial fibrillation in cancer","volume":"63","author":"Farmakis","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0036","first-page":"2269","article-title":"Hypertension and risk of renal cell carcinoma among white and black Americans","volume":"134","author":"Colt","year":"2011","journal-title":"Epidemiology"},{"key":"2026012115084535000_ehf212551-bib-0037","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.thromres.2010.10.001","article-title":"Arterial thrombosis in ambulatory cancer patients treated with chemotherapy","volume":"127","author":"Di Nisio","year":"2011","journal-title":"Thromb Res"},{"key":"2026012115084535000_ehf212551-bib-0038","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0002-9149(03)00546-0","article-title":"Echocardiographic features of radiation-associated valvular disease","volume":"92","author":"Hering","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0039","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000091638","article-title":"Pulmonary arterial hypertension after childhood cancer therapy and bone marrow transplantation","volume":"105","author":"Limsuwan","year":"2006","journal-title":"Cardiology"},{"key":"2026012115084535000_ehf212551-bib-0040","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/STROKEAHA.111.615203","article-title":"O\u00b4Sullivan JD and Read SJ. Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review","volume":"42","author":"Plummer","year":"2011","journal-title":"Stroke"},{"key":"2026012115084535000_ehf212551-bib-0041","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1182\/blood-2014-09-594432","article-title":"Vascular safety issues in CML patients treated with BCR\/ABL1 kinase inhibitors","volume":"125","author":"Valent","year":"2015","journal-title":"Blood"},{"key":"2026012115084535000_ehf212551-bib-0042","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cvr\/cvz031","article-title":"Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment","volume":"115","author":"Chow","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2026012115084535000_ehf212551-bib-0043","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/annonc\/mdr348","article-title":"Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors","volume":"23","author":"Serrano","year":"2012","journal-title":"Ann Oncol"},{"key":"2026012115084535000_ehf212551-bib-0044","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/ejhf.1252","article-title":"Cancer and heart failure-more than meets the eye: common risk factors and co-morbidities","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0045","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ Res"},{"key":"2026012115084535000_ehf212551-bib-0046","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ejhf.1336","article-title":"How to build a cardio-oncology service?","volume":"20","author":"Farmakis","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0047","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1073\/pnas.1601650113","article-title":"Oncometabolite d-2-hydroxyglutarate impairs \u03b1-ketoglutarate dehydrogenase and contractile function in rodent heart","volume":"113","author":"Karlstaedt","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012115084535000_ehf212551-bib-0048","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"2026012115084535000_ehf212551-bib-0049","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2017.05.013","article-title":"Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study","volume":"81","author":"Boerman","year":"2017","journal-title":"Eur J Cancer"},{"key":"2026012115084535000_ehf212551-bib-0050","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"2026012115084535000_ehf212551-bib-0051","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cvr\/cvz035","article-title":"Common risk factors for heart failure and cancer","volume":"115","author":"Meijers","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2026012115084535000_ehf212551-bib-0052","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1539","article-title":"Cancer and heart disease: associations and relations","author":"de Boer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0053","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012115084535000_ehf212551-bib-0054","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1634\/theoncologist.2018-0116","article-title":"Canakinumab and lung cancer: intriguing, but is it real?","volume":"23","author":"Chabner","year":"2018","journal-title":"Oncologist"},{"key":"2026012115084535000_ehf212551-bib-0055","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"2026012115084535000_ehf212551-bib-0056","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2014.07.948","article-title":"Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer","volume":"64","author":"Cramer","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0057","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/ejhf.670","article-title":"Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study","volume":"18","author":"Anker","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0058","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10549-016-3938-1","article-title":"Resting heart rate as a prognostic factor for mortality in patients with breast cancer","volume":"159","author":"Lee","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"2026012115084535000_ehf212551-bib-0059","article-title":"Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence","volume":"13","author":"Park","year":"2018","journal-title":"PLoS One"},{"key":"2026012115084535000_ehf212551-bib-0060","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/ejhf.921","article-title":"The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology","volume":"19","author":"van Bilsen","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0061","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.recesp.2016.12.021","article-title":"Cardio-onco-hematology in clinical practice. Position paper and recommendations","volume":"70","author":"L\u00f3pez-Fern\u00e1ndez","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026012115084535000_ehf212551-bib-0062","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0063","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.echo.2017.06.026","article-title":"Feasibility and accuracy of automated software for transthoracic three-dimensional left ventricular volume and function analysis: comparisons with two-dimensional echocardiography, three-dimensional transthoracic manual method, and cardiac magnetic resonance imaging","volume":"30","author":"Tamborini","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012115084535000_ehf212551-bib-0064","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jcmg.2018.01.015","article-title":"Abnormalities in 3-dimensional left ventricular mechanics with anthracycline chemotherapy are associated with systolic and diastolic dysfunction","volume":"11","author":"Zhang","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012115084535000_ehf212551-bib-0065","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jcmg.2018.03.019","article-title":"Negishi K and Marwick TH; SUCCOUR investigators. Rationale and design of the strain surveillance of chemotherapy for improving cardiovascular outcomes: The SUCCOUR trial","volume":"11","author":"Negishi","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012115084535000_ehf212551-bib-0066","first-page":"487","article-title":"Emerging cardiac imaging modalities for the early detection of cardiotoxicity due to anticancer therapies","volume":"70","author":"Lopez-Fernandez","year":"2017","journal-title":"Rev Esp Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0067","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ejhf.1385","article-title":"Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients","volume":"21","author":"Keramida","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2019.04.026","article-title":"Long term cardiovascular magnetic resonance phenotyping of anthracycline cardiomyopathy","author":"Harries","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0069","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14737159.2017.1283219","article-title":"Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy","volume":"17","author":"Cardinale","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"2026012115084535000_ehf212551-bib-0070","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation od adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012115084535000_ehf212551-bib-0071","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1373\/clinchem.2005.050153","article-title":"N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction?","volume":"51","author":"Sandri","year":"2005","journal-title":"Clin Chem"},{"key":"2026012115084535000_ehf212551-bib-0072","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jacc.2013.10.061","article-title":"Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab","volume":"63","author":"Ky","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0073","first-page":"116","article-title":"Circulating miRNA profiles of doxorubicin-induced cardiotoxicity in breast cancer patients","volume":"47","author":"Todorova","year":"2017","journal-title":"Ann Clin Lab Sci"},{"key":"2026012115084535000_ehf212551-bib-0074","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","article-title":"Evaluation and management of patients with heart disease and cancer: cardio-oncology","volume":"89","author":"Herrmann","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"2026012115084535000_ehf212551-bib-0075","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.amjcard.2013.08.026","article-title":"Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity","volume":"112","author":"Lotrionte","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0076","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-981-10-4304-8_8","article-title":"The positive effects of exercise in chemotherapy-related cardiomyopathy","volume":"1000","author":"Cavarretta","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"2026012115084535000_ehf212551-bib-0077","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/2047487318811181","article-title":"Exercise as a diagnostic and theapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients","volume":"26","author":"Howden","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026012115084535000_ehf212551-bib-0078","first-page":"139:e997","article-title":"Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association","author":"Gilchrist","year":"2019","journal-title":"Circulation"},{"key":"2026012115084535000_ehf212551-bib-0079","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Asssessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012115084535000_ehf212551-bib-0080","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1200\/JCO.2001.19.13.3163","article-title":"Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study","volume":"19","author":"Mertens","year":"2001","journal-title":"J Clin Oncol"},{"key":"2026012115084535000_ehf212551-bib-0081","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2012.45.2938","article-title":"Late cardiac effects of cancer treatment","volume":"30","author":"Lenihan","year":"2012","journal-title":"J Clin Oncol"},{"key":"2026012115084535000_ehf212551-bib-0082","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"2026012115084535000_ehf212551-bib-0083","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehy453","article-title":"Cardio-oncology services: rationale, organization, and implementation: a report from the ESC cardio-oncology council","volume":"40","author":"Lancellotti","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012115084535000_ehf212551-bib-0084","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/ejhf.1292","article-title":"Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience","volume":"20","author":"Pareek","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012115084535000_ehf212551-bib-0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"2026012115084535000_ehf212551-bib-0086","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000495576","article-title":"Ivabradine in cancer treatment-related left ventricular dysfunction","volume":"63","author":"Sarocchi","year":"2018","journal-title":"Chemotherapy"},{"key":"2026012115084535000_ehf212551-bib-0087","article-title":"The reverse remodelling response to sacubitril\/valsartan therapy in heart failure with reduced ejection fraction","volume":"36","author":"Mertens","year":"2018","journal-title":"Cardiovasc Therapy"},{"key":"2026012115084535000_ehf212551-bib-0088","volume-title":"S-LBCT02-04","author":"Heart Rhythm Congress","year":"2019"},{"key":"2026012115084535000_ehf212551-bib-0089","volume-title":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02164721"},{"key":"2026012115084535000_ehf212551-bib-0090","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","article-title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","volume":"19","author":"Hodi","year":"2018","journal-title":"Lancet Oncol"},{"key":"2026012115084535000_ehf212551-bib-0091","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(15)70054-9","article-title":"Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial","volume":"16","author":"Rizvi","year":"2015","journal-title":"Lancet Oncol"},{"key":"2026012115084535000_ehf212551-bib-0092","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/cvr\/cvz026","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors","volume":"115","author":"Hu","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2026012115084535000_ehf212551-bib-0093","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","article-title":"Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis","volume":"391","author":"Moslehi","year":"2018","journal-title":"Lancet"},{"key":"2026012115084535000_ehf212551-bib-0094","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1470-2045(18)30457-1","article-title":"Immune checkpoint inhibitors and cardiovascular toxicity","volume":"19","author":"Lyon","year":"2018","journal-title":"Lancet Oncol"},{"key":"2026012115084535000_ehf212551-bib-0095","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/cvr\/cvz026","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors","volume":"115","author":"Hu","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2026012115084535000_ehf212551-bib-0096","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science (New York, NY)"},{"key":"2026012115084535000_ehf212551-bib-0097","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2174\/0929867324666170407125017","article-title":"Immune checkpoint inhibitors and cardiac toxicity: an emerging issue","volume":"25","author":"Varricchi","year":"2018","journal-title":"Curr Med Chem"},{"key":"2026012115084535000_ehf212551-bib-0098","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"key":"2026012115084535000_ehf212551-bib-0099","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cell.2019.05.047","article-title":"Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors","volume":"178","author":"Ponzetta","year":"2019","journal-title":"Cell"},{"key":"2026012115084535000_ehf212551-bib-0100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/CIRCULATIONAHA.117.030352","article-title":"Phosphoinositide 3-kinase gamma inhibition protects from anthracycline cardiotoxicity and reduces tumor growth","volume":"138","author":"Li","year":"2018","journal-title":"Circulation"},{"key":"2026012115084535000_ehf212551-bib-0101","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fphys.2018.00382","article-title":"Cardiac remodelling: endothelial cells have more to say than just no","volume":"9","author":"Segers","year":"2018","journal-title":"Front Phsysiol"},{"key":"2026012115084535000_ehf212551-bib-0102","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1161\/CIRCULATIONAHA.118.036099","article-title":"Endothelial cells regulate physiological cardiomyocyte growth via VEGFR2-mediated paracrine signaling","volume":"139","author":"Kivel\u00e4","year":"2019","journal-title":"Circulation"},{"key":"2026012115084535000_ehf212551-bib-0103","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/CIRCULATIONAHA.118.033603","article-title":"Linking heart failure to cancer","volume":"138","author":"Bertero","year":"2018","journal-title":"Circulation"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12551","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12551","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/6\/1140\/66136297\/eschf_6_6_1140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/6\/1140\/66136297\/eschf_6_6_1140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:11:07Z","timestamp":1769026267000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/6\/6\/1140\/8403502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":103,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,12,28]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12551","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,12,1]]},"assertion":[{"value":"2019-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}